Skip to main content

Atle Fund Management AB

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 1381843 STOCKHOLM, V7

Position in NAMS

as of Jun 30, 2026 · filed Jul 24, 2026
Position Value
$8,433,458
+$5,399,039 QoQ
Shares Held
248,848
+162.5% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
2.27%
of 13F equity value
Holder Rank
#53
of 198 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NAMS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Atle Fund Management AB holds $141,162,145 across 21 Biotechnology names. NAMS ranks #8 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NAMS
NewAmsterdam Pharma Co N.V.
This page
248,848 $8,433,458

All Filings in NAMS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,433,458 248,848
2026-03-31 $3,034,419 94,796
2025-12-31 $6,912,022 197,036
2025-09-30 $584,612 193,625
2025-06-30 $2,847,308 157,223
2025-03-31 $2,206,318 107,783
2024-12-31 $3,571,863 138,983
2024-09-30 $2,307,117 138,983
2024-06-30 $1,456,002 75,794
2024-03-31 $529,618 22,394